Fat Metabolism & Lipotropics Research blend
AOD + Tesamorelin + MOTS-c
Metabolic blend
Research blend of AOD9604, a modified growth hormone fragment, tesamorelin, a GHRH analogue, and MOTS-c, a mitochondria-encoded peptide.
Evidence level. Little or no public data, or the exact identity is still being confirmed. For a blend, the rating covers the combination itself; each component has its own profile. About the badges
- Class
- Metabolic blend
- Category
- Fat Metabolism & Lipotropics
- Type
- Research blend
- Development and regulatory status
- Combination not approved; tesamorelin approved alone for HIV lipodystrophy
Blend composition
AOD 5 mg + Tesamorelin 5 mg + MOTS-c 5 mg (15 mg kit); 20 mg kit in 11-vial packs
Each component is profiled separately in the catalogue: AOD9604, Tesamorelin, MOTS-c (Human).
What researchers study
A research blend of AOD9604 (a modified growth hormone fragment studied for lipolysis), tesamorelin (a growth hormone-releasing hormone analogue) and MOTS-c (a mitochondria-encoded regulatory peptide). The components act on fat metabolism, the GH axis and mitochondrial signalling.
Research areas
- Combined fat-metabolism, GH-axis and mitochondrial pathway studies
- Visceral fat biology
- Comparing single-agent and multi-pathway effects
Reported findings
Summaries of published results. Each one is tagged with the type of study behind it. They describe research outcomes and are not claims about any product. Why study type matters.
- literature check
No published studies of this three-component combination were identified
- phase 3 trial
Tesamorelin: in two placebo-controlled trials in 816 HIV-positive adults with abdominal fat, greater CT-measured abdominal fat reductions than placebo, reported as 15-17%
- rodent
In mice given MOTS-c, age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity were not observed
Studied alongside
Compounds that appear together in research because their mechanisms complement each other, or as comparators. The reasons given are research reasoning, not recommendations for use.
- AOD9604modified growth hormone fragment, a component of this blend
- TesamorelinGHRH analogue, a component of this blend
- MOTS-c (Human)mitochondria-encoded peptide, a component of this blend
